Public disclosure of inside information according to article 17 MAR
Vidac Pharma Holding PLC: Planned Application for Inclusion to the Open Market of Stock Exchange Düsseldorf (Sub-Segment Primary Market)
London (pta023/20.10.2025/19:35 UTC+2)
VIDAC PHARMA HOLDING PLC herewith announces that it intends to apply for its shares to be included in the open market of the Düsseldorf Stock Exchange, sub-segment Primary Market. The inclusion of the shares in the open market of the Düsseldorf Stock Exchange (Primary Market), in addition to the existing listings on the open markets of the Hamburg, Stuttgart, and Berlin stock exchanges, is intended to further increase the tradability of the shares for the benefit of investors, in particular through the subsequent inclusion of the shares in XETRA-trading. As things stand at present, the inclusion of the shares in the open market of the Düsseldorf Stock Exchange (Primary Market) is planned for the beginning of November. The inclusion is subject to the approval of the Düsseldorf Stock Exchange and therefore cannot be predicted with certainty at this stage.
(end)
Emitter: |
Vidac Pharma Holding PLC 20-22 Wenlock Road N1 7GU London United Kingdom |
![]() |
---|---|---|
Contact Person: | Sven Radke | |
Phone: | +972-544-999951 | |
E-Mail: | sandragamzon@gmail.com | |
Website: | www.vidacpharma.com | |
ISIN(s): | GB00BM9XQ619 (Share) | |
Stock Exchange(s): | Free Market in Berlin, Hamburg, Stuttgart |